Duncker Streett & Co’s Covetrus, Inc. Common Stock CVET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-800
Closed -$17K 516
2022
Q3
$17K Hold
800
﹤0.01% 374
2022
Q2
$17K Hold
800
﹤0.01% 379
2022
Q1
$13K Hold
800
﹤0.01% 404
2021
Q4
$16K Hold
800
﹤0.01% 429
2021
Q3
$15K Hold
800
﹤0.01% 427
2021
Q2
$22K Sell
800
-640
-44% -$17.9K ﹤0.01% 403
2021
Q1
$43K Hold
1,440
0.01% 348
2020
Q4
$41K Hold
1,440
0.01% 355
2020
Q3
$35K Sell
1,440
-214
-13% -$4.62K 0.01% 347
2020
Q2
$30K Sell
1,654
-920
-36% -$12.1K 0.01% 353
2020
Q1
$21K Sell
2,574
-1,600
-38% -$18.3K 0.01% 387
2019
Q4
$55K Buy
+4,174
New +$50.5K 0.01% 345
2019
Q3
Sell
-7,140
Closed -$175K 534
2019
Q2
$175K Sell
7,140
-3,806
-35% -$110K 0.04% 261
2019
Q1
$348K Buy
+10,946
New +$389K 0.08% 209

Other funds holding CVET

Duncker Streett & Co's CVET Position: Q4 2022 in Review

Duncker Streett & Co sold out of Covetrus, Inc. Common Stock (CVET) in Q4 2022, closing a stake of 800 shares — an estimated $17K sold.

Duncker Streett & Co first reported a position in CVET in Q1 2019 and held it in 14 quarters. The position peaked at $348K in Q1 2019. 5 funds tracked by Wall St. Rank hold CVET as of Q4 2022.

  • Duncker Streett & Co reported no remaining Covetrus, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Duncker Streett & Co sold 800 Covetrus, Inc. Common Stock shares in Q4 2022, an estimated $17K.
  • Duncker Streett & Co first reported a position in Covetrus, Inc. Common Stock in Q1 2019 and held it in 14 quarters.
  • Duncker Streett & Co's Covetrus, Inc. Common Stock position peaked at $348K in Q1 2019.
  • 5 funds tracked by Wall St. Rank held Covetrus, Inc. Common Stock as of Q4 2022.

Based on Duncker Streett & Co's 13F filing for Q4 2022, filed 25 Jan 2023.